EurekAlert! -
27 Jan 2020 07:00
(Case Western Reserve University) A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the US Food and Drug Administration (FDA).
Share this Article